STOCK TITAN
  1. Home
  2. News
  3. WVE

Wave Life Sciences Ltd. - WVE STOCK NEWS

IMPACT
SENTIMENT
WVE : Nasdaq
Wave Life Sciences to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference
conferences
IMPACT
SENTIMENT
WVE : Nasdaq
Wave Life Sciences to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference
conferences
IMPACT
SENTIMENT
WVE : Nasdaq
Wave Life Sciences Prices $100 Million Public Offering of Ordinary Shares
offering
IMPACT
SENTIMENT
WVE : Nasdaq
Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares
offering
IMPACT
SENTIMENT
WVE : Nasdaq
Wave Life Sciences to Highlight Preclinical ADAR Editing Data and Neurology Programs at TIDES and OTS Annual Meetings
IMPACT
SENTIMENT
WVE : Nasdaq
Wave Life Sciences to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
conferences
IMPACT
SENTIMENT
WVE : Nasdaq
Wave Life Sciences to Highlight PRISM Platform Advancements and Preclinical Neurology Pipeline During Analyst and Investor Research Webcast
IMPACT
SENTIMENT
WVE : Nasdaq
Wave Life Sciences to Webcast Conference Call of Second Quarter 2020 Financial Results on August 10, 2020
conferences earnings
IMPACT
SENTIMENT
WVE : Nasdaq
Wave Life Sciences to Present at the Jefferies 2020 Virtual Healthcare Conference
conferences
IMPACT
SENTIMENT
WVE : Nasdaq
Wave Life Sciences Appoints Dr. Ken Rhodes as Senior Vice President, Therapeutics Discovery
management
Stock WVE logo
Wave Life Sciences Ltd.

Nasdaq:WVE

WVE Rankings

#3558 Ranked by Market Cap
#1217 Ranked by Stock Gains
N/A Ranked by Dividends

WVE Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Singapore
7 Straits View

About WVE

wave life sciences ltd. (nasdaq: wve) is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering new treatment options for patients. given the unique versatility of its chemistry platform, wave’s pipeline spans multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded rnai.